Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$15.86B
-56.45
95.76%
3 Buy
0 Hold
0 Sell
Strong Buy
Ascletis Pharma, Inc.
HK$12.33
HK$13.40B
-46.49
227.16%
1 Buy
0 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$12.11
HK$30.99B
30.93
76.79%
2 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.27B
-15.98
57.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$17.06B
130.45
497.20%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
57.75
28.60
98.11%
HK:1672
Ascletis Pharma, Inc.
13.25
9.24
230.42%
HK:2096
Simcere Pharmaceutical Group Limited
12.11
5.30
77.83%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.95
2.06
71.28%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.89
5.81
57.64%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
47.00
39.09
494.18%